Lexaria Bioscience (LEXX) Other financing activities (2011 - 2024)

Lexaria Bioscience (LEXX) posted Other financing activities of -$2875.0 for Q3 2024, down 100.06% sequentially from $5.0 million in Q2 2024.

Lexaria Bioscience (LEXX) Other financing activities (2011 - 2024) Analysis & Trends

Lexaria Bioscience has reported Other financing activities for 10 years, with the latest figure at -$2875.0 in Q3 2024.

Quarterly Other financing activities changed N/A year-over-year to -$2875.0 in Q3 2024, while the trailing twelve-month figure through Aug 2025 was $5.0 million (down 17.42% YoY) and the FY2024 annual result came in at $6.1 million, changed N/A from the prior year.
Other financing activities eased to -$2875.0 in Q3 2024 per LEXX's latest filing, from $5.0 million in the prior quarter.
Over five years, Other financing activities peaked at $5.0 million in Q2 2024 and troughed at -$600000.0 in Q3 2022.
A 5-year average of $1.2 million and a median of $491824.0 in 2024 frame the typical range for Other financing activities.
The sharpest annual moves came in 2021 and 2022: Other financing activities soared 214035.63% in 2021, then slumped 114.94% in 2022.
Over 5 years, Other financing activities stood at $1875.0 in 2020, then jumped by 214035.63% to $4.0 million in 2021, then tumbled by 114.94% to -$600000.0 in 2022, then surged by 195.28% to $571651.0 in 2023, then plunged by 100.5% to -$2875.0 in 2024.
According to Business Quant data, Other financing activities over the past three periods registered -$2875.0, $5.0 million, and $491824.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Lexaria Bioscience	10.15 Mn	6.54 Mn	-

Download Data